Navigation Links
Successful Diabetes Product Launches Balance Digital & Traditional Public Relations Tools
Date:1/4/2012

CHAPEL HILL, N.C., Jan. 4, 2012 /PRNewswire/ -- Successfully launching a new diabetes product in this digital age still relies heavily on traditional public relations tools, namely press releases, media interviews, health fairs, and educational pamphlets. However, introducing new technologies into a launch plan is an effective way to inform patients and physicians of the new product.

Among the most effective technologies for reaching patients and physicians about a new diabetes product are online advocacy groups, branded web sites, and e-newsletters, according to commercial executives who participated in primary research on "Educating the Marketplace to Support Successful Diabetes Product Launches" conducted by Best Practices, LLC. Podcasts are one of the least effective technologies for informing patients, but achieve some success in reaching physicians.

Download a complimentary white paper at http://www3.best-in-class.com/rr1139.htm that includes selected best practices drawn from extensive primary research with executives from 26 leading companies.

Key insights from other areas of the research include:

  • 89% of companies start engaging thought leaders and key investigators in clinical trial protocol development at Phase II or before. The largest response groups signaled Phase II as the kickoff to most thought leader services.
  • Engaging thought leaders and key investigators in clinical trial protocol development is rated by 94% of companies as one of the most important thought leader education activities.

"Educating the Marketplace to Support Successful Diabetes Product Launches," a primary research study conducted by Best Practices, LLC, is a 161-page report with more than 450 benchmark metrics and 41 executive narratives, providing launch leaders the most effective physician, payer and patient education practices conducted from clinical development through launch.

Executives and managers in the diabetes therapeutic area use this research to compare their market education tactics and strategies with those of leading organizations.

For more information on this study and other recent primary research studies, contact us at 919.403.0251 or at bestpractices@best-in-class.com.

BEST PRACTICES, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies.

The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.

Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Valeant Announces Successful Results From Phase III Onychomycosis Trials
2. Successful ILM-Blue Patent Opposition Proceedings Before the European Patent Office; Patent Validity Confirmed
3. Successful Market Education Strategies and Tactics for New Pharmaceutical Product Launches in the Oncology Therapeutic Area
4. Pieris Announces Results and Successful Completion of its PRS-050 Anticalin Phase I Trial at AACR-EORTC-NCI Molecular Targets and Cancer Therapeutics Conference
5. Mylan Successfully Upsizes and Completes Refinancing of Credit Facility
6. GeckoSystems Successfully Applies Its Mobile Robot Solutions to Improve Wheelchair Safety
7. NephroGenex Announces the Successful Completion of PYR-210
8. AtheroNova Completes Successful Pre-IND Meeting with FDA on AHRO-001
9. Elusys Initiates Third Clinical Safety Study of Anthim, a New Anthrax Treatment; Company Successfully Completes Manufacturing at Commercial Scale
10. Market Education Tactics and Strategies to Support Successful Oncology Product Launches
11. Mylans Dey Pharma Successfully Obtains Patent Reexamination Certificates for Two Perforomist® Patents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... , Dec. 9, 2016 aTyr Pharma, Inc. (Nasdaq: ... development of Physiocrine-based therapeutics to address severe, rare diseases, today announced ... upcoming BMO Prescriptions for Success Healthcare Conference at the InterContinental Barclay ... December 14, 2016, at 4:20 p.m. ET. About ... ...
(Date:12/9/2016)... , Dec. 9, 2016 Department of Health ... regulations for medical marijuana dispensaries under Act 16 are ... , and are now available online . ... in the plan for operation; process for dispensing medical ... well as where the dispensary facilities can be located," ...
(Date:12/8/2016)... VIEW, Calif. , Dec. 8, 2016 IRIDEX ... intends to offer newly issued shares of common stock, $0.01 ... pursuant to an underwritten public offering.  The final terms of ... the time of pricing, and there can be no assurance ... IRIDEX expects to use the net proceeds it ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... December 08, 2016 , ... The West Virginia Medical Institute ... The name change aligns the entire company with its existing Quality Insights ... , “We are very proud of the achievements associated with the West Virginia ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... ... 08, 2016 , ... Mirixa Corporation , a leading ... pharmacist-delivered patient care services, has announced the promotions of Karen Litsinger to senior ... of sales. , Litsinger joined Mirixa in 2008 after serving as a ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... David ... with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, ... of the DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... development continuity to its innovative Unified Instance Manager architecture, meeting the needs ... this new version optimizes the unattended auto-dialing system without agents, Presence Robodialer, ...
Breaking Medicine News(10 mins):